Bioptik Technology, Inc.(TW:4161)
NT$21.10+0.25 (+1.20%)
TW:4161
Bioptik Technology, Inc. financials statements
NT$21.10
At close:+0.25 (+1.20%)
Bioptik Technology, Inc. (4161) Income Statement
Bioptik Technology, Inc. Income Statement
Last quarter (Q2 2026), Bioptik Technology, Inc.'s total revenue was NT$237.60M, an increase of 24.73% from the same quarter last year. In Q2, Bioptik Technology, Inc.'s net income was NT$38.57M. See Bioptik Technology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 837.19M | NT$ 865.34M | NT$ 828.50M | NT$ 767.75M | NT$ 737.89M | |
| NT$ 243.51M | NT$ 267.90M | NT$ 239.54M | NT$ 177.46M | NT$ 163.54M | |
| NT$ 176.78M | NT$ 177.91M | NT$ 149.29M | NT$ 138.20M | NT$ 128.10M | |
| Depreciation and Amortization | NT$ 32.77M | NT$ 35.64M | NT$ 34.72M | NT$ 33.47M | NT$ 36.98M |
| NT$ 99.50M | NT$ 155.10M | NT$ 152.18M | NT$ 105.47M | NT$ 64.41M | |
| NT$ 66.73M | NT$ 89.99M | NT$ 90.25M | NT$ 71.78M | NT$ 27.14M | |
| NT$ 18.58M | NT$ 20.48M | NT$ 16.22M | NT$ -8.97M | NT$ -7.53M | |
| NT$ 85.32M | NT$ 110.32M | NT$ 106.47M | NT$ 62.81M | NT$ 19.62M | |
| NT$ 71.19M | NT$ 93.57M | NT$ 85.71M | NT$ 48.50M | NT$ 22.59M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.23 | NT$ 1.84 | NT$ 1.68 | NT$ 1.00 | NT$ 0.45 |
| Diluted EPS | NT$ 1.23 | NT$ 1.80 | NT$ 1.67 | NT$ 1.00 | NT$ 0.45 |
| Weighted Average Shares Outstanding | 56.78M | 50.98M | 51.02M | 50.69M | 50.68M |
| Weighted Average Shares Outstanding (Diluted) | 56.78M | 51.92M | 51.32M | 50.93M | 50.76M |
Currency in TWD

